-
1
-
-
33645527991
-
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
-
Issue 10.1002/14651858.CD003476.pub2. [DOI: 10.1002/14651858.CD003476. pub2]
-
Ballard C, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 10.1002/14651858.CD003476.pub2. [DOI: 10.1002/14651858.CD003476.pub2]
-
(2006)
Cochrane Database of Systematic Reviews
-
-
Ballard, C.1
Waite, J.2
Birks, J.3
-
2
-
-
43249092442
-
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
-
DOI 10.1371/journal.pmed.0050076, e76
-
Ballard C, Margallo Lana M, Theodoulou M, Douglas S, McShane R, Jacoby R, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DARTAD trial). PLoS Medicine 2008;5:e76. (Pubitemid 351649258)
-
(2008)
PLoS Medicine
, vol.5
, Issue.4
, pp. 587-599
-
-
Ballard, C.1
Lana, M.M.2
Theodoulou, M.3
Douglas, S.4
McShane, R.5
Jacoby, R.6
Kossakowski, K.7
Yu, L.-M.8
Juszczak, E.9
-
3
-
-
58649100881
-
The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial
-
January 9, DOI: 10.1016/S1474-4422(08)70295-3
-
Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet January 9, 2009;DOI: 10.1016/S1474-4422(08) 70295-3.
-
(2009)
The Lancet
-
-
Ballard, C.1
Hanney, M.L.2
Theodoulou, M.3
-
4
-
-
21744449949
-
The quality of antipsychotic drug prescribing in nursing homes
-
DOI 10.1001/archinte.165.11.1280
-
Briesacher B, Limcangco M, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine 2005;165:1280-1285 (Pubitemid 40989593)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.11
, pp. 1280-1285
-
-
Briesacher, B.A.1
Limcangco, M.R.2
Simoni-Wastila, L.3
Doshi, J.A.4
Levens, S.R.5
Shea, D.G.6
Stuart, B.7
-
6
-
-
70049114483
-
-
US Food and Drug Administration Public Health Advisory. Accessed June 27
-
US Food and Drug Administration Public Health Advisory. Antipsychotics are not indicated for the treatment of dementia-related psychosis. http://www.fda.gov/cder/drug/InfoSheets/HCP/antipsychotics-conventional.htm Accessed June 27, 2008.
-
(2008)
Antipsychotics Are Not Indicated for the Treatment of Dementia-related Psychosis.
-
-
-
7
-
-
29144508843
-
Global Prevalence of dementia: A Delphi consensus study
-
for Alzheimer's Disease International
-
Ferri C, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. for Alzheimer's Disease International. Global Prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117
-
(2005)
Lancet
, vol.366
, pp. 2112-2117
-
-
Ferri, C.1
Prince, M.2
Brayne, C.3
Brodaty, H.4
Fratiglioni, L.5
Ganguli, M.6
-
8
-
-
0030428313
-
Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment
-
DOI 10.1017/S1041610297003943
-
Finkel S, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics 1996;8(Suppl 3):497-500. (Pubitemid 27229556)
-
(1996)
International Psychogeriatrics
, vol.8
, Issue.SUPPL. 3
, pp. 497-500
-
-
Finkel, S.I.1
Costa E Silva, J.2
Cohen, G.3
Miller, S.4
Sartorius, N.5
-
9
-
-
19144372322
-
Effects of memantine on behavioural symptoms in Alzheimer's disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
-
DOI 10.1002/gps.1341
-
Gauthier S, Wirth Y, Mobius H. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the neuropsychiatric inventory (NPI) data of two randomised, controlled studies. International Journal of Geriatric Psychiatry 2005;20:459-464 (Pubitemid 40716339)
-
(2005)
International Journal of Geriatric Psychiatry
, vol.20
, Issue.5
, pp. 459-464
-
-
Gauthier, S.1
Wirth, Y.2
Mobius, H.J.3
-
10
-
-
0033890206
-
Are behavioral and psychological symptoms of dementia associated with mortality in Alzheimer's disease?
-
Gilley DW. Are behavioral and psychological symptoms of dementia associated with mortality in Alzheimer's disease?. International Psychogeriatrics 2000;12:63-66 (Pubitemid 30599664)
-
(2000)
International Psychogeriatrics
, vol.12
, Issue.SUPPL. 1
, pp. 63-66
-
-
Gilley, D.W.1
-
11
-
-
33750150319
-
The contribution of neuropsychiatric symptoms to the cost of dementia care
-
DOI 10.1002/gps.1594
-
Herrmann N, Lanctôt K, Sambrook R, et al. The contribution of neuropsychiatric symptoms to the cost of dementia care. International Journal of Geriatric Psychiatry 2006;21(10):972-976. (Pubitemid 44596392)
-
(2006)
International Journal of Geriatric Psychiatry
, vol.21
, Issue.10
, pp. 972-976
-
-
Herrmann, N.1
Lanctot, K.L.2
Sambrook, R.3
Lesnikova, N.4
Hebert, R.5
McCracken, P.6
Robillard, A.7
Nguyen, E.8
-
13
-
-
34948834261
-
Donepezil for the treatment of agitation in Alzheimer's disease
-
DOI 10.1056/NEJMoa066583
-
Howard R, Juszczak E, Ballard C, Bentham P, Brown R, Bullock R, et al. Donezepil for the treatment of agitation in Alzheimer's disease. New England Journal of Medicine 2007;357:1382-1392 (Pubitemid 47535593)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.14
, pp. 1382-1392
-
-
Howard, R.J.1
Juszczak, E.2
Ballard, C.G.3
Bentham, P.4
Brown, R.G.5
Bullock, R.6
Burns, A.S.7
Holmes, C.8
Jacoby, R.9
Johnson, T.10
Knapp, M.11
Lindesay, J.12
O'Brien, J.T.13
Wilcock, G.14
Katona, C.15
Jones, R.W.16
Decesare, J.17
Rodger, M.18
-
15
-
-
29144517795
-
Primary care use of antipsychotic drugs: An audit and intervention study
-
DOI 10.1186/1744-859X-4-18
-
Mortimer A, Shepherd C, Rymer M, et al. Primary care use of antipsychotic drugs: an audit and intervention study. Annals of General Psychiatry 2005;4:18. (Pubitemid 41800140)
-
(2005)
Annals of General Psychiatry
, vol.4
, Issue.1
, pp. 18
-
-
Mortimer, A.M.1
Shepherd, C.J.2
Rymer, M.3
Burrows, A.4
-
16
-
-
47849102514
-
Antipsychotics for people with dementia
-
doi:10.1136/bmj.a602
-
O'Brien J. Antipsychotics for people with dementia. BMJ 2008;337: a602 doi:10.1136/bmj.a602.
-
(2008)
BMJ
, vol.337
-
-
O'Brien, J.1
-
17
-
-
39049135306
-
Clustering of behavioural and psychological symptoms in dementia (BPSD): A european alzheimer's disease consortium (EADC) study
-
Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, et al. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's Disease in Consortium (EADC) Study. Acta Clinica Belgica 2007;62(6):426-432 (Pubitemid 351236176)
-
(2007)
Acta Clinica Belgica
, vol.62
, Issue.6
, pp. 426-432
-
-
Petrovic, M.1
Hurt, C.2
Collins, D.3
Burns, A.4
Camus, V.5
Liperoti, R.6
Marriott, A.7
Nobili, F.8
Robert, P.9
Tsolaki, M.10
Vellas, B.11
Verhey, F.12
Byrne, E.J.13
-
18
-
-
27944508285
-
Grouping for behavioral and psychological symptoms in dementia: Clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium
-
DOI 10.1016/j.eurpsy.2004.09.031, PII S0924933804002573
-
Robert P, Verhey F, Byrne E, Hurt C, De Deyn P, Nobili F, et al. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. European Psychiatry 2005;20:490-496 (Pubitemid 41681558)
-
(2005)
European Psychiatry
, vol.20
, Issue.7
, pp. 490-496
-
-
Robert, P.H.1
Verhey, F.R.J.2
Byrne, E.J.3
Hurt, C.4
De Deyn, P.P.5
Nobili, F.6
Riello, R.7
Rodriguez, G.8
Frisoni, G.B.9
Tsolaki, M.10
Kyriazopoulou, N.11
Bullock, R.12
Burns, A.13
Vellas, B.14
-
19
-
-
12844274439
-
Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
-
DOI 10.1001/jama.293.5.596
-
Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia. A review of the evidence. JAMA 2005;293:596-608. (Pubitemid 40171242)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.5
, pp. 596-608
-
-
Sink, K.M.1
Holden, K.F.2
Yaffe, K.3
-
20
-
-
46749095495
-
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
-
DOI 10.1176/appi.ajp.2008.07111779
-
Sultzer D, Davis S, Tariot P, et al. Clinical Symptom Responses to Atypical Antipsychotic Medication in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial. Am J Psychiatry 2008;165:844-854. (Pubitemid 351948716)
-
(2008)
American Journal of Psychiatry
, vol.165
, Issue.7
, pp. 844-854
-
-
Sultzer, D.L.1
Davis, S.M.2
Tariot, P.N.3
Dagerman, K.S.4
Lebowitz, B.D.5
Lyketsos, C.G.6
Rosenheck, R.A.7
Hsiao, J.K.8
Lieberman, J.A.9
Schneider, L.S.10
-
22
-
-
33846905932
-
Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients
-
DOI 10.1177/0891988706292762
-
Zuidema S, Koopmans R, Verhey F. Prevalence and Predictors of Neuropsychiatric Symptoms in Cognitively Impaired Nursing Home Patients. Journal of Geriatric Psychiatry and Neurology 2007;20:41-49 (Pubitemid 46233618)
-
(2007)
Journal of Geriatric Psychiatry and Neurology
, vol.20
, Issue.1
, pp. 41-49
-
-
Zuidema, S.1
Koopmans, R.2
Verhey, F.3
|